TY - JOUR
T1 - Antiphospholipid antibodies in early repeated abortions
T2 - A case-controlled study
AU - Barbui, T.
AU - Cortelazzo, S.
AU - Galli, M.
AU - Parazzini, F.
AU - Radici, E.
AU - Rossi, E.
AU - Finazzi, G.
PY - 1988
Y1 - 1988
N2 - The relation among lupus anticoagulant (LAC), anticardiolipin antibodies (ACA), and repeated abortions was evaluated in a case-controlled study of 49 women with two or more unexplained spontaneous abortions (cases) compared with 141 control subjects, who had had one or more normal pregnancies and no previous spontaneous abortion. The women were admitted to the same hospital where the cases had been identified for acute conditions other than immunologic neoplastic, gynecologic or cardiovascular. LAC was detected in 7 out of 49 cases (14%, 95% confidence limits 8% to 26%) but in none of the 141 controls. Similarly, ACA were detected in four cases (8%, 95% confidence limits 0.3% to 30%) but no controls. These differences in frequency were statistically significant. These findings confirm that LAC and ACA are associated with a history of repeated abortions in clinically asymptomatic patients for immunologic conditions.
AB - The relation among lupus anticoagulant (LAC), anticardiolipin antibodies (ACA), and repeated abortions was evaluated in a case-controlled study of 49 women with two or more unexplained spontaneous abortions (cases) compared with 141 control subjects, who had had one or more normal pregnancies and no previous spontaneous abortion. The women were admitted to the same hospital where the cases had been identified for acute conditions other than immunologic neoplastic, gynecologic or cardiovascular. LAC was detected in 7 out of 49 cases (14%, 95% confidence limits 8% to 26%) but in none of the 141 controls. Similarly, ACA were detected in four cases (8%, 95% confidence limits 0.3% to 30%) but no controls. These differences in frequency were statistically significant. These findings confirm that LAC and ACA are associated with a history of repeated abortions in clinically asymptomatic patients for immunologic conditions.
UR - http://www.scopus.com/inward/record.url?scp=0023720388&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023720388&partnerID=8YFLogxK
M3 - Article
C2 - 3139464
AN - SCOPUS:0023720388
SN - 0015-0282
VL - 50
SP - 589
EP - 592
JO - Fertility and Sterility
JF - Fertility and Sterility
IS - 4
ER -